2016-2020 Emerging US Enteric Disease Testing Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia-Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts
![](/report_cover/2215/2016-emerging-us-enteric-disease-testing-market-campylobacter-cryptosporidium-e-coli-enterovirus-rhinovirus-rotavirus_en.gif)
Complete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $3,500. This new 314-page report from VPGMarketResearch.com provides analysis of the US enteric disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.
About This Report
This report presents detailed analysis of the Enteric Disease market in the US. Current scientific views on epidemiology and etiology are presented for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrioand Yersinia. The report provides test volume and sales forecasts and market segment, including: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health Labs In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of enteric disease diagnostic products, by tests. Also, the report: - Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; - Reviews features and operating characteristics of major analyzers used for enteric disease testing; - Profiles key suppliers and potential market entrants developing innovative technologies and products; and - Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.
Methodology
The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U. S. In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearchs proprietary data files was conducted.
Contains 314 pages and 22 tables
About This Report
This report presents detailed analysis of the Enteric Disease market in the US. Current scientific views on epidemiology and etiology are presented for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrioand Yersinia. The report provides test volume and sales forecasts and market segment, including: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health Labs In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of enteric disease diagnostic products, by tests. Also, the report: - Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; - Reviews features and operating characteristics of major analyzers used for enteric disease testing; - Profiles key suppliers and potential market entrants developing innovative technologies and products; and - Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.
Methodology
The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U. S. In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearchs proprietary data files was conducted.
Contains 314 pages and 22 tables
INTRODUCTION
WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Infectious Disease Tests
1. Campylobacter
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. Cryptosporidium
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. E. Coli
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Enteroviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. RhinoViruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. RotaVirus (REOVIRUS)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
7. Salmonellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. Shigellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. Vibrio
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
10. Yersinia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatech/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako
WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Infectious Disease Tests
1. Campylobacter
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. Cryptosporidium
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. E. Coli
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Enteroviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. RhinoViruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. RotaVirus (REOVIRUS)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
7. Salmonellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. Shigellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. Vibrio
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
10. Yersinia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatech/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako
LIST OF TABLES
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Yersinia Tests
U.S.A. Campylobacter Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Campylobacter Diagnostics Sales by Major Supplier
U.S.A. Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Cryptosporidium Diagnostics Sales by Major Supplier
U.S.A. E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Enterovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Enterovirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Rotavirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Rotavirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. Salmonella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Salmonella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Shigella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Shigella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Vibrio Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Yersinia Tests
U.S.A. Campylobacter Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Campylobacter Diagnostics Sales by Major Supplier
U.S.A. Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Cryptosporidium Diagnostics Sales by Major Supplier
U.S.A. E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Enterovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Enterovirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Rotavirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Rotavirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. Salmonella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Salmonella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Shigella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Shigella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Vibrio Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment